Loading…

Assoc. Prof. Pramote Tragulpiankit

Department of Pharmacy


  pramote.tra@mahidol.ac.th

Education Background

  • B,Sc, in Pharm.
  • M.S. (Pharm)
  • Ph.D.

Work Experience

Expertise

  • Pharmacovigilance, Medication Safety

Award & Honor

  • Figure 1: Discuss on Pharmacovigilance in Thailand at the New Western Pacific Chapter of ISoP at the 7th ISoP annual meeint in 2007.
  • Figure 2: Won the first place at the Pharmacovigilance Quiz Bowl in the 5th International Society of Pharmacovigilance (ISoP) Annual Meeting in 2005.

Current Research


Publication

Year 2026

Year 2025

2.

Knowledge, Attitude, Practice, and Barriers of Adverse Drug Reaction Reporting Among Healthcare Professionals in Timor-Leste: A Cross-Sectional Survey

da Costa J; Nosoongnoen W; Rungapiromnan W; Tragulpiankit P.
Clinical and Translational Science 2025 Jan;9(1):69-81 , 2025.

Year 2024

3.

Effect of pharmacist-led interventions on hypertension-related knowledge, medication adherence, and blood pressure control: A multi-center, randomized, controlled trial in Vietnam

Huynh BH; Vo HT; Pham ATK; Tragulpiankit P; Huynh NH; Nguyen NL; Nguyen LT; Hong Pham T; Nathisuwan S.
JACCP Journal of the American College of Clinical Pharmacy 2024; 7():544-553 , 2024.

4.

Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review

Surarak T; Chumnumwat S; Nosoongnoen W; Tragulpiankit P.
Clinical and Translational Science 2024; (e13795):- , 2024.

Year 2023

5.

Drug-Related Problems and Pharmacists' Interventions in Hypertensive Outpatients: A Multicenter Prospective Study in 3 Vietnamese Hospitals

Huynh BH; Nathisuwan S; Tragulpiankit P; Nguyen VD; Huynh NH; Vu TLA; Huynh LTH; Vo HT.
Journal of Pharmacy Technology 2023 Dec;39(6):259-268 , 2023.

Year 2022

6.

Costs Associated with Adverse Drug Reactions Among HIV/TB Patients in Thailand

Rochanathimoke O, Tragulpiankit P, Turongkaravee S, Jittikoon J, Udomsinprasert W, Chaikledkeaw U.
Clinicoecon Outcomes Res 2022 Sep 7;14:587-599 , 2022.

7.

The Evaluation of Meropenem Dosing Regimens Against ESBL-Producing Escherichia coli in ICU Patients Using Monte Carlo Simulation

Win EE, Htun KW, Tragulpiankit P, Tangtrakultham S, Montakantikul P.
Infection and Drug Resistance 2022 Feb 11;15:439-453 , 2022.

8.

The effect of Cissus quadrangularis L. on delaying bone loss in postmenopausal women with osteopenia: A randomized placebo-controlled trial

Benjawan S, Nimitphong H, Tragulpiankit P, Musigavong O, Prathanturarug S, Pathomwichaiwat T.
Phytomedicine 2022 Sep 23;86(10):1368-1377 , 2022.

Year 2021

9.

Colistin dosing regimens against pseudomonas aeruginosa in critically ill patients: An application of monte carlo simulation

Nguyen VTK, Montakantikul P, Tragulpiankit P, Houngsaitong J, Shuib MF..
Antibiotics 2021; 10(5): 595., 2021.

10.

HLA-A*24:07 as a potential biomarker for carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Filipino patients

Capule F, Tragulpiankit P, Mahasirimongkol S, Jittikoon J, Wichukchinda N, Alentajan-Aleta LT, Barit J-VJ, Casanova-Gutierrez J, Cabral-Lim L, Baltazar Reyes JP, Roa F, Salonga R, San Gabriel KF, Silao CL..
Pharmacogenomics 2021; 22(8): 465-472., 2021.

Year 2020

11.

Association of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B*15:21 allele in Filipino patients.

Capule F*, Tragulpiankit P, Mahasirimongkol S, Jittikoon J, Wichukchinda N, Theresa Alentajan-Aleta L, James Barit JV, Casanova-Gutierrez J, Cabral-Lim L, Baltazar Reyes JP, Roa F, Salonga R, San Gabriel KF, Lynn Silao C..
Pharmacogenomics journal 2020; 20(3): 533-541., 2020.

12.

Knowledge, attitude, and practice towards pharmacogenomics among hospital pharmacists in Thailand

Karuna N, Tragulpiankit P, Mahasirimongkol S, Chumnumwat S*..
Pharmacogenet genomics 2020; 30(4): 73-80., 2020.

13.

The efficacy of honey and a Thai Herbal Oil preparation in the treatment of pressure ulcers based on Thai traditional medicine wound diagnosis versus standard practice: An open-label randomized controlled trial

Chotchoungchatchai S, Krairit O, Tragulpiankit P, Prathanturarug S*..
Contemporary clinical trials communications 2020; 17: 100538., 2020.

Year 2019

14.

Pharmacokinetics and penetration of sitafloxacin into alveolar epithelial lining fluid in critically ill Thai patients with pneumonia

Paiboonvong T, Nosoongnoen W*, Sathirakul K*, Tangsujaritvijit V, Kaemapairoj J, Tragulpiankit P*, Montakantikul P*..
Antimicrob Agents Chemother 2019; 63(10)., 2019.

Year 2018

15.

Carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a Filipino with positive HLA-B75 serotype

Capule F, Tragulpiankit P, Mahasirimongkol S, Wichukchinda N, Jittikoon J, Alentajan-Aleta LT, Jay-V James Barit, Casanova-Gutierrez J, Cabral-Lim L, Baltazar Reyes JP, Roa F, Katrina Faith San Gabriel, Catherine Lynn Silao..
BMJ Case Reports 2018 (Article in Press), 2018.

16.

Education on antimicrobials, antimicrobial resistance, and infectious diseases in pharmacy curricula, Thailand

Paiboonvong T, Pummangura C, Tedtaisong P, Thamlikitkul V, Tragulpiankit P, Suansanae T, Sukkha S, Montakantikul P.*.
Pharmaceutical Sciences Asia 2018; 45(2): 105-113, 2018.

Year 2016

17.

Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations

Jittikoon J, Mahasirimongkol S, Charoenyingwattana A, Chaikledkaew U, Tragulpiankit P, Mangmool S, Inunchot W, Somboonyosdes C, Wichukchinda N, Sawanpanyalert P, He Y.f, Mcleod H.L.f, Chantratita W*..
Journal of Human Genetics. 2016; 61(2): 119-127., 2016.

18.

Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey

Dorji C, Tragulpiankit P*, Riewpaiboon A, Tobgay T..
Drug Safety 2016; 39(12): 1239-1250., 2016.

Year 2015

19.

Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.

Jittikoon J, Mahasirimongkol S, Charoenyingwattana A, Chaikledkaew U, Tragulpiankit P, Mangmool S, Inunchot W, Somboonyosdes C, Wichukchinda N, Sawanpanyalert P, He Y, McLeod HL, Chantratita W*..
Journal of Human Genetics 2015; 1-9, 2015.

20.

Evaluation of Thai and Narnajo’s Algorithm for Assessing Routine Pharmacovigilance Case Reports Using WHO-UMC Causality Assessment Criteria as Reference

Suwankesawong W, Sriphiromya P, Tragulpiankit P, Phetcharat C, Sornsrivichai V, Pokhagul P..
Drug Safety 2015; 38(10): 1019-1020, 2015.

21.

Knowledge About Adverse Drug Reaction and Reporting Among the Healthcare Professionals in Bhutan

Dorji C, Tragulpiankit P, Riewpaiboon A, Tobgay T..
Drug Safety 2015; 38(10): 946-946, 2015.

22.

Patterns of Spontaneously Reported Adverse Drug Reaction in Bhutan

Dorji C, Tragulpiankit P, Dema N..
Drug Safety 2015; 38(10): 981-981, 2015.

Year 2014

23.

Adverse Drug Event of Hospitalized Patients from Multi-Hospitals in Thailand

Tragulpiankit P, Yeesoonpan N, Ninsananda T, Chindavijak B, Chulavatnatol S, Chaikledkaew U, Uaviseswong T..
Pharmacoepidemiology and drug safety 2014; 23: 289-289, 2014.

24.

Drug Discrepancy and Medication Error of Admitted Patients by Medication Reconciliation Process

Unin J, Tragulpiankit P, Ningsananda T, Nilpetchploy R..
Pharmacoepidemiology and drug safety 2014; 23: 122-123, 2014.

25.

Drug-Related Hospital Readmission in Community Hospital, Thailand

Unin J, Tragulpiankit P, Moungnoi C, Channalao P..
Pharmacoepidemiology and drug safety 2014; 23: 123-123, 2014.

Year 2013

26.

Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal.

KC S, Tragulpiankit P*, Gorsanan S, Edwards R..
BMC Pharmacology and Toxicology 2013; 14-16., 2013.

27.

Knowledge about adverse drug reactions reporting among healthcare professionals in Nepal

Kc S, Tragulpiankit P*, Edwards IR, Gorsanan S..
International Journal of Risk and Safety in Medicine 2013; 25(1): 1-16, 2013.

28.

Strengthening the Pharmacovigilance Programme in Nepal

Santosh KC, Tragulpiankit P*, Gorsanam P, Edwards IR, Alam K..
Nepal Journal of Epidemiology 2013; 3(1): 230-235, 2013.

Year 2012

29.

A prospective, randomized, double dummy, placebo-controlled trial of oral cefditoren pivoxil 400 mg once daily as switch therapy after intravenous ceftriaxone in the treatment of acute pyelonephritis

Monmaturapoj T, Montakantikul P, Mootsikapun P*, Tragulpiankit P..
International Journal of Infectious Diseases 2012; 16(12): 843-849, 2012.

30.

Adverse drug events in rheumatoid arthritis and osteoarthritis ambulatory patients

Tragulpiankit P*, Chulavatnatol S, Rerkpattanapipat T, Janwityanujit S, Somjarit S, Sirikhedgon U..
International Journal of Rheumatic Diseases 2012; 15(3): 315-321, 2012.

31.

Systematic Review of Economic Evaluation of Pharmacist Intervention Related to Adverse Drug Event Prevention among Patients with Hospitalization.

Uaviseswong T, Chaikledkaew U*, Tragulpiankit P..
Mahidol University Journal of Pharmaceutical Sciences 2012; 39(1): 38-43., 2012.

Year 2011

32.

Measured versus estimated creatinine clearance in elderly patients

Tragulpiankit P, Montakantikul P, Chulavatnatol S, Chansirikarnjana S, Thawinwang A..
Journal of Applied Therapeutic Research 2011; 8(2): 43-51, 2011.

Year 2009

33.

Incidence of Medication Errors in Medication Reconciliation at General Medical Wards, Ramathibodi Hospital

Paiboonvong T, Montakantikul P*, Chansirikarnjana S, Tragulpiankit P..
Mahidol J Pharm. Sci 2009; 36(1-4): 44-49., 2009.

34.

Pharmacist Participation in the Reduction of Preventable Adverse Drug Reactions in Thai Hospitalised Patients

Tragulpiankit P, Kaojarern S, Pummangura C, Wananukul W, Luscombe DK..
Journal of Applied Therapeutic Research 2009;7(1), 2009.

Year 2008

35.

Prevalence and characteristics of adverse drug events in rheumatoid arthritis and osteoarthritis ambulatory patients at a large teaching hospital, Thailand.

Limsuwan T, Tragulpiankit P, Chulavatnatol S, Janwityanujit S, Sirikhedgon U, Somjarit S..
European Journal of Dermatology 2008;18:262-3., 2008.

Year 2007

36.

Adverse Drug Event of Rheumatoid Arthritis and Osteoarthritis Ambulatory Patients in a Large

Tragulpiankit P, Chulavatnatol S, Limsuwan,T , Sirikhedgon U, Somjarit S.
Drug Safety 2007; 30(10): 950., 2007.

37.

Development of a New Causality Assessment Method for Thai Adverse Drug Reaction Monitoring and Reporting

Suwankesawong W, Tragulpiankit P, Yothapitak J, Songsiriphun R..
Drug Safety 2007; 30(10): 948.., 2007.

38.

Drug Therapy Problem Management by Pharmacist in Paediatric Intensive Care Unit at a Large Teaching Hospital, Thailand

Piebpien P, Tragulpiankit P, Preutthipan A, Montakantikul P..
Drug Safety 2007; 30(10): 949, 2007.

Year 2006

39.

Preliminary review of Thai pharmacists

Tragulpiankit P, Chulavatnatol S..
Drug Saf 2006;29:976., 2006.

Year 2005

40.

Prevention of adverse drug reactions in hospitalised patients by pharmacist participation at a large teaching hospital in Thailand.

Tragulpiankit P, Pummangura C, Luscombe DK, Kaojarern S, Wananukul W, Montakantikul P, Nathisuwan S..
Drug Safety 2005;28(10):931., 2005.

Year 2004

41.

Characteristics of adverse drug reactions and patient at risk in medical wards.

Pummangura C, Tragulpiankit P, Kaojarern S, Wananukul W, Montakantikul P, Luscombe DK, Pomyen N. .
Pharmacy World & Science 2004;26:A100., 2004.

42.

Reducing the risk of drug-induced adverse events in hospitalized patients.

Tragulpiankit P, Kaojarern S, Wananukul W, Luscombe DK. .
Pharmacy World & Science 2004;26:A100., 2004.

Year 2003

43.

Characteristics of adverse drug reactions and patients at risk in medical wards, Ramathibodi Hospital.

Pummangura C, Tragulpiankit P, Kaojaroen S, Wananukul W, Montakantikul P,Luscombe DK, Pomyen N. .
Mahidol University Journal of Pharmaceutical Sciences 2003;30(3):25-31., 2003.

Year 2002

44.

Potential adverse drug interaction in prescriptions of patients with cardiovascular diseases.

Chulavatnatol S, Tragulpiankit P, Ruengcharoenrung K, Janpraparn J, Aumklad P. .
Thai Journal of Hospital Pharmacy 2002;12(1):18-30., 2002.

Year 2001

45.

Drug allergy history study of ambulatory patients.

Tragulpiankit P, Ruengcharoenrung K, Avihingsanon S, Cheadchaykeat M, Maneepan Y. .
Thai Journal of Hospital Pharmacy 2001;11(3):19-28., 2001.

Year 1999

46.

An inpatient surveillance of adverse drug reactions in medical wards, in a teaching hospital, Thailand.

Tragulpiankit P, Wananukul W.
European Journal of Clinical Pharmacology 1999;55A47., 1999.

Year 1996

47.

In-patient adverse drug reaction monitoring at the Department of Medicine, Ramathibodi Hospital.

Chindavijak B, Tragulpiankit P, Kaojarern S, Pummangura C..
Ramathibodi Med J 1996, 19: 17-25., 1996.


Presentation

Year 2018

1.

Pharmacist’s Role in Risk Reduction of Carbamazepine-induced Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis through Biomarker Testing

Capule F, Tragulpiankit P..
18th Asian Conference on Clinical Pharmacy (ACCP) 2018 , 2018.

Year 2015

2.

Adverse Drug Events Identified by Thai ADEs Trigger Tool in Hospitalized Patients in Thailand

Paiboonvon T, Tragulpiankit P, Viriyakul N, Iamchoo W, Promtasarn K, Sangviroon A.
Drug Safety 2015; 38(10): 1018-1018, 2015.

3.

Evaluation of Thai and Narnajo’s Algorithm for Assessing Routine Pharmacovigilance Case Reports Using WHO-UMC Causality Assessment Criteria as Reference

Suwankesawong W, Sriphiromya P, Tragulpiankit P, Phetcharat C, Sornsrivichai V, Pokhagul P..
Drug Safety 2015; 38(10): 1019-1020, 2015.

4.

Knowledge About Adverse Drug Reaction and Reporting Among the Healthcare Professionals in Bhutan

Dorji C, Tragulpiankit P, Riewpaiboon A, Tobgay T..
Drug Safety 2015; 38(10): 946-946, 2015.

5.

Patterns of Spontaneously Reported Adverse Drug Reaction in Bhutan

Dorji C, Tragulpiankit P, Dema N..
Drug Safety 2015; 38(10): 981-981, 2015.

Year 2013

6.

A meta-anlysis of genetic variation in CYP2C19 gene on drug interaction between clopidogrel and proton pump inhibitors in patients with cardiovascular diseases

Kritsanapipat D*, Jaroenporn P, Jittikoon J, Chaikedkaew U, Tragulpiankit P, Mahasirimongkol S, Charoenyingwattana A, Suvichapanich S, Sanrattana W, Chantratita W..
Pharma Indochina VIII ASEAN Pharmacy - Integration for Development, Vietnam. on 4 - 5 December 2013 , 2013.

Year 2008

7.

Prevalence and characteristics of adverse drug events in rheumatoid arthritis and osteoarthritis ambulatory patients at a large teaching hospital, Thailand.

Limsuwan T, Tragulpiankit P, Chulavatnatol S, Janwityanujit S, Sirikhedgon U, Somjarit S..
3rd Drug Hypersensitivity Meeting , 11-13 April, 2008, Paris , 2008.

8.

Training Course For Improvement Of Thai Adr Monitoring And Reporting.

Tragulpiankit P..
22nd Federation of Asian Pharmaceutical Associations Congress (FAPA 2008), 7 – 10 November 2008, Grand Copthorne Waterfront Hotel, Singapore. , 2008.

Year 2006

9.

Measured versus estimated creatinine clearance in Thai elderly patients.

Thawinwang A, Montakantikul P, Chansirikarnjana S, Chulavatnatol S, Tragulpiankit P..
งานประชุมวิชาการประจำปี สมาคมเภสัชกรรมโรงพยาบาล (ประเทศไทย) เรื่อง ”The Next Step of Hospital Pharmacist to Quality Pharmacy Service” ณ อาคารเฉลิมพระบารมี ๕๐ ปี แพทยสมาคมฯ กรุงเทพฯ วันที่ 17 - 19 พฤษภาคม พ.ศ. 2549. 2006, 2006.

Year 2002

10.

Pharmacist participation in therapeutic phenytoin monitoring. (oral presentation)

Chulavatnatol S, Tragulpiankit P, Chanawong A, Viranuvatti K, Wananukul W..
งานประชุมวิชาการประจำปี สมาคมเภสัชกรรมโรงพยาบาล (ประเทศไทย) เรื่อง ”Facing Changes in Pharmacotherapy and Pharmacy Profession” กรุงเทพฯ วันที่ 22 - 24 พฤษภาคม พ.ศ. 2545. 2002, 2002.

Year 2001

11.

ปฏิกิริยาระหว่างยาที่พบในใบสั่งยาของผู้ป่วยโรคหัวใจ

สุวัฒนา จุฬาวัฒนทล ปราโมทย์ ตระกูลเพียรกิจ กมลศักดิ์ เรืองเจริญรุ่ง จารุณี จันทร์ประพาฬ ปอรวัลย์ อ่ำกลัด..
งานประชุมวิชาการประจำปี สมาคมเภสัชกรรมโรงพยาบาล (ประเทศไทย) เรื่อง “DUE: A Stepwise Approach for Rational Drug Use” กรุงเทพฯ วันที่ 23 - 25 พฤษภาคม พ.ศ. 2544. 2001, 2001.

เกี่ยวกับภาควิชา

The ultimate success of a pharmacist's practice relies on applying expertise to minimize the consumer's risk of harm from medication while maximizing the positive outcomes in disease prevention and treatment.

The ultimate success of a pharmacist's practice relies on applying expertise to minimize the consumer's risk of harm from medication while maximizing the positive outcomes in disease prevention and treatment.
Pradit Hutangura
The First Dean of Faculty of Pharmacy, Mahidol University
Copyright © 2021 - 2026
Division of Information Technology and Instructional Media, Faculty of Pharmacy, Mahidol University.
Cookie Notice
This site uses cookies from us and our partners to make your browsing experience more efficient, relevant, convenient and personal. In some cases, they are essential to making the site work properly. By accessing this site, you direct us to use and consent to the use of cookies. You can change your settings by clicking on the Cookie Settings link.